Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Adeno-Associated Viral Vectors Market Report 2024

Adeno-Associated Viral Vectors Global Market Report 2024 – By Type Of Therapy (Gene Augmentation, Immunotherapy, Other Type Of Therapies), By Type Of Gene Delivery Method Used (Ex Vivo, In Vivo), By Target Therapeutic Area (Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas ), By Scale Of Operation (Preclinical, Clinical, Commercial), By Application Area (Gene Therapy, Cell Therapy, Vaccines) – Market Size, Trends, And Global Forecast 2024-2033

Adeno-Associated Viral Vectors Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : July 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Adeno-Associated Viral Vectors Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Adeno-Associated Viral Vectors Market Definition And Segments

Adeno-associated viral vectors (AAV) are small, non-pathogenic viruses commonly used in gene therapy. They are engineered to deliver therapeutic genes into target cells, offering potential treatments for genetic disorders, cancers, and other diseases. AAV's safety profile and ability to efficiently infect both dividing and non-dividing cells make them valuable tools in biomedical research and clinical applications.

The main type of adeno-associated viral vectors therapy are gene augmentation, immunotherapy, and others. Gene augmentation is a technique where a functional gene is introduced to replace or supplement a defective or missing gene in a patient's cells. The type of gene delivery method are ex vivo and in vivo, which works on target therapeutic areas such as genetic disorders, hematological disorders, infectious diseases, metabolic disorders, ophthalmic disorders, muscle disorders, neurological disorders, and others. The scale of operation includes preclinical, clinical, and commercial, applied for gene therapy, cell therapy, and vaccines.

The adeno-associated viral vectors market covered in this report is segmented –

1) By Type Of Therapy: Gene Augmentation, Immunotherapy, Other Type Of Therapies

2) By Type Of Gene Delivery Method Used: Ex Vivo, In Vivo

3) By Target Therapeutic Area: Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas

4) By Scale Of Operation: Preclinical, Clinical, Commercial

5) By Application Area: Gene Therapy, Cell Therapy, Vaccines

The adeno-associated viral vectors market size has grown rapidly in recent years. It will grow from $2.29 billion in 2023 to $2.69 billion in 2024 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to vaccine development, increased funding and investment, academic and industrial collaborations, expansion of clinical trials, and public awareness and advocacy.

The adeno-associated viral vectors market size is expected to see rapid growth in the next few years. It will grow to $5.17 billion in 2028 at a compound annual growth rate (CAGR) of 17.7%. The growth in the forecast period can be attributed to expanding therapeutic applications, increasing the prevalence of genetic disorders, and neurological disorders, regulatory approvals and support, and cost reductions in production. Major trends in the forecast period include gene therapy advancements, technological innovations, scalable manufacturing processes, collaborations and investments, and technological advancements.

Rising Prevalence Of Genetic Disorders Fuels Growth In The Adeno-Associated Viral Vectors Market

The increasing prevalence of genetic disorders is expected to propel the growth of the adeno-associated viral vectors market going forward. Genetic disorders are conditions caused by abnormalities in an individual's DNA, leading to physical or developmental abnormalities. The improved diagnostic techniques, greater awareness, and higher reproductive age, along with environmental factors and genetic drift are leading to the rise in the prevalence of genetic disorders. Adeno-associated viral vectors are utilized in gene therapy for genetic disorders, delivering corrective genes into target cells to potentially treat conditions like muscular dystrophy or cystic fibrosis. For instance, in February 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, congenital diseases caused an estimated 240,000 baby deaths globally within 28 days of birth each year. An additional 170,000 children between the ages of 1 month and 5 years die as a result of congenital diseases. Therefore, the increasing prevalence of genetic disorders is driving the adeno-associated viral vectors market.

Major companies operating in the adeno-associated viral vectors market are Pfizer Inc., Astellas Pharma, Biogen Inc., Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics, Ultragenyx Pharmaceutical, Amicus Therapeutics Inc., Oxford Biomedica, Asklepios BioPharmaceutical Inc., uniQure biopharma B.V., Spark Therapeutics Inc., Akouos inc., Adverum Biotechnologies Inc., Passage Bio Inc., AVROBIO Inc, MeiraGTx Holdings plc, GenSight Biologics S.A., Freeline Therapeutics, Aspa Therapeutics Inc., Adrenas Therapeutics Inc., 4D Molecular Therapeutics, Abeona Therapeutics Inc., Neurophth Therapeutics

Advancements In Off-the-Shelf Rep/Cap Plasmids

Major companies operating in the adeno-associated viral vectors market are focusing on offering off-the-shelf availability of replication-capsid plasmid to gain a competitive edge in the market. Rep/Cap plasmids, commonly utilized in gene therapy for adeno-associated virus (AAV) vector production, are readily available from numerous commercial suppliers catering to molecular biology research needs. For instance, in January 2024, Charles River Laboratories International Inc., a US-based pharmaceutical company, introduced off-the-shelf replication-capsid plasmid range streamlines AAV-based gene therapy initiatives. This expansion of their product portfolio complements existing lentiviral packaging and AAV Helper plasmid offerings, cutting manufacturing efforts by as much as 66%. These ready-to-use plasmids undergo batch production with meticulous documentation, adhering to CMC guidelines and accompanied by Certification of Analysis (COA) to facilitate IND and Clinical Trial Application (CTA) submissions.

Charles River Laboratories International Inc. Acquires Vigene Biosciences Inc. To Bolster Presence In Cell And Gene Therapy CDMO Sector

In June 2021, Charles River Laboratories International Inc., a US-based pharmaceutical company, acquired Vigene Biosciences Inc. for $292.5 million. The acquisition is aimed to enhance the Charles’ capabilities in the high-growth cell and gene therapy contract development and manufacturing organization (CDMO) sector. Vigene Biosciences Inc. is a US-based contract development and manufacturing (CDMO) company providing solutions for cell and gene therapy, including adeno-associated viral vectors.

North America was the largest region in the adeno-associated viral vectors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adeno-associated viral vectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the adeno-associated viral vectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The adeno-associated viral vectors market consists of sales of recombinant adeno-associated viral vectors (AAV), serotype-specific adeno-associated viral vectors (AAV), and custom adeno-associated viral vectors (AAV). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The adeno-associated viral vectors market research report is one of a series of new reports from The Business Research Company that provides adeno-associated viral vectors market statistics, including adeno-associated viral vectors industry global market size, regional shares, competitors with a adeno-associated viral vectors market share, detailed adeno-associated viral vectors market segments, market trends and opportunities, and any further data you may need to thrive in the adeno-associated viral vectors industry. This adeno-associated viral vectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Adeno-Associated Viral Vectors Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.69 billion
Revenue Forecast In 2033 $5.17 billion
Growth Rate CAGR of 17.7% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type Of Therapy: Gene Augmentation, Immunotherapy, Other Type Of Therapies
2) By Type Of Gene Delivery Method Used: Ex Vivo, In Vivo
3) By Target Therapeutic Area: Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By Application Area: Gene Therapy, Cell Therapy, Vaccines
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Astellas Pharma, Biogen Inc., Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics, Ultragenyx Pharmaceutical, Amicus Therapeutics Inc., Oxford Biomedica, Asklepios BioPharmaceutical Inc., uniQure biopharma B.V., Spark Therapeutics Inc., Akouos inc., Adverum Biotechnologies Inc., Passage Bio Inc., AVROBIO Inc, MeiraGTx Holdings plc, GenSight Biologics S.A., Freeline Therapeutics, Aspa Therapeutics Inc., Adrenas Therapeutics Inc., 4D Molecular Therapeutics, Abeona Therapeutics Inc., Neurophth Therapeutics
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Adeno-Associated Viral Vectors Market Characteristics

    3. Adeno-Associated Viral Vectors Market Trends And Strategies

    4. Adeno-Associated Viral Vectors Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Adeno-Associated Viral Vectors Market Size and Growth

    5.1. Global Adeno-Associated Viral Vectors Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Adeno-Associated Viral Vectors Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Adeno-Associated Viral Vectors Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Adeno-Associated Viral Vectors Market Segmentation

    6.1. Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Gene Augmentation

    Immunotherapy

    Other Type Of Therapies

    6.2. Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Ex Vivo

    In Vivo

    6.3. Global Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Genetic Disorders

    Hematological Disorders

    Infectious Diseases

    Metabolic Disorders

    Ophthalmic Disorders

    Muscle Disorders

    Neurological Disorders

    Other Target Therapeutic Areas

    6.4. Global Adeno-Associated Viral Vectors Market, Segmentation By Scale Of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Preclinical

    Clinical

    Commercial

    6.5. Global Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Gene Therapy

    Cell Therapy

    Vaccines

    7. Adeno-Associated Viral Vectors Market Regional And Country Analysis

    7.1. Global Adeno-Associated Viral Vectors Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Adeno-Associated Viral Vectors Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Adeno-Associated Viral Vectors Market

    8.1. Asia-Pacific Adeno-Associated Viral Vectors Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Adeno-Associated Viral Vectors Market

    9.1. China Adeno-Associated Viral Vectors Market Overview

    9.2. China Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Adeno-Associated Viral Vectors Market

    10.1. India Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Adeno-Associated Viral Vectors Market

    11.1. Japan Adeno-Associated Viral Vectors Market Overview

    11.2. Japan Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Adeno-Associated Viral Vectors Market

    12.1. Australia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Adeno-Associated Viral Vectors Market

    13.1. Indonesia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Adeno-Associated Viral Vectors Market

    14.1. South Korea Adeno-Associated Viral Vectors Market Overview

    14.2. South Korea Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Adeno-Associated Viral Vectors Market

    15.1. Western Europe Adeno-Associated Viral Vectors Market Overview

    15.2. Western Europe Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Adeno-Associated Viral Vectors Market

    16.1. UK Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Adeno-Associated Viral Vectors Market

    17.1. Germany Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Adeno-Associated Viral Vectors Market

    18.1. France Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Adeno-Associated Viral Vectors Market

    19.1. Italy Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Adeno-Associated Viral Vectors Market

    20.1. Spain Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Adeno-Associated Viral Vectors Market

    21.1. Eastern Europe Adeno-Associated Viral Vectors Market Overview

    21.2. Eastern Europe Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Adeno-Associated Viral Vectors Market

    22.1. Russia Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Adeno-Associated Viral Vectors Market

    23.1. North America Adeno-Associated Viral Vectors Market Overview

    23.2. North America Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Adeno-Associated Viral Vectors Market

    24.1. USA Adeno-Associated Viral Vectors Market Overview

    24.2. USA Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Adeno-Associated Viral Vectors Market

    25.1. Canada Adeno-Associated Viral Vectors Market Overview

    25.2. Canada Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Adeno-Associated Viral Vectors Market

    26.1. South America Adeno-Associated Viral Vectors Market Overview

    26.2. South America Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Adeno-Associated Viral Vectors Market

    27.1. Brazil Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Adeno-Associated Viral Vectors Market

    28.1. Middle East Adeno-Associated Viral Vectors Market Overview

    28.2. Middle East Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Adeno-Associated Viral Vectors Market

    29.1. Africa Adeno-Associated Viral Vectors Market Overview

    29.2. Africa Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Adeno-Associated Viral Vectors Market Competitive Landscape And Company Profiles

    30.1. Adeno-Associated Viral Vectors Market Competitive Landscape

    30.2. Adeno-Associated Viral Vectors Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Astellas Pharma

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Biogen Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Charles River Laboratories International Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. BioMarin Pharmaceutical Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Adeno-Associated Viral Vectors Market Other Major And Innovative Companies

    31.1. Sarepta Therapeutics Inc.

    31.2. PTC Therapeutics

    31.3. Ultragenyx Pharmaceutical

    31.4. Amicus Therapeutics Inc.

    31.5. Oxford Biomedica

    31.6. Asklepios BioPharmaceutical Inc.

    31.7. uniQure biopharma B.V.

    31.8. Spark Therapeutics Inc.

    31.9. Akouos inc.

    31.10. Adverum Biotechnologies Inc.

    31.11. Passage Bio Inc.

    31.12. AVROBIO Inc

    31.13. MeiraGTx Holdings plc

    31.14. GenSight Biologics S.A.

    31.15. Freeline Therapeutics

    32. Global Adeno-Associated Viral Vectors Market Competitive Benchmarking

    33. Global Adeno-Associated Viral Vectors Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Adeno-Associated Viral Vectors Market

    35. Adeno-Associated Viral Vectors Market Future Outlook and Potential Analysis

    35.1 Adeno-Associated Viral Vectors Market In 2028 - Countries Offering Most New Opportunities

    35.2 Adeno-Associated Viral Vectors Market In 2028 - Segments Offering Most New Opportunities

    35.3 Adeno-Associated Viral Vectors Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Adeno-Associated Viral Vectors Market, Segmentation By Scale Of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Adeno-Associated Viral Vectors Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Adeno-Associated Viral Vectors Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: Pfizer Inc. Financial Performance
  • Table 77: Astellas Pharma Financial Performance
  • Table 78: Biogen Inc. Financial Performance
  • Table 79: Charles River Laboratories International Inc. Financial Performance
  • Table 80: BioMarin Pharmaceutical Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Adeno-Associated Viral Vectors Market, Segmentation By Type Of Gene Delivery Method Used, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Adeno-Associated Viral Vectors Market, Segmentation By Scale Of Operation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Adeno-Associated Viral Vectors Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Adeno-Associated Viral Vectors Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Type Of Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Target Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Adeno-Associated Viral Vectors Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: Pfizer Inc. Financial Performance
  • Figure 77: Astellas Pharma Financial Performance
  • Figure 78: Biogen Inc. Financial Performance
  • Figure 79: Charles River Laboratories International Inc. Financial Performance
  • Figure 80: BioMarin Pharmaceutical Inc. Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Viral Vectors And Plasmid DNA Global Market Report 2024 – By Product (Plasmid DNA, Viral Vectors), By Disease (Infectious Diseases, Genetic Disorders, Cancer, Other Diseases), By Application (Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications), By End User (Research Institutes, Biopharmaceutical And Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Bacterial And Plasmid Vectors Global Market Report 2024 – By Host Type (E.Coli Expression Vectors, Other Bacterial Expression Vectors), By Application (Genetics, Molecular Biology, Bioinformatics, Other Applications), By End Users (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Adenosine Triphosphate (ATP) Assays Global Market Report 2024 – By Type (Luminometric ATP (Adenosine Triphosphate) Assays, Enzymatic ATP (Adenosine Triphosphate) Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays, Cell-Based ATP (Adenosine Triphosphate) Assays, Other Types), By Component (Consumables And Accessories, Instruments), By Application (Drug Discovery And Development, Clinical Diagnostics, Environmental Testing, Food Safety And Quality Testing, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Food and Beverage Industry, Hospitals And Diagnostics Laboratories, Academic And Research Institutions) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Viral Inactivation Global Market Report 2024 – By Product (Kits And Reagents, Systems, Services), By Method (Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods), By Application (Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
The Antiviral & Antimicrobial Coatings Global Market Report 2024 – By Type (Antimicrobial Coatings, Antiviral Coatings), By Material (Silver, Organic Materials, Copper, Aluminum, Silicon Dioxide), By Form (Liquid, Powder, Aerosol), By Application (Healthcare, Building And Construction, Food And Beverage, Packaging, Automotive, Protective Clothing, Air And Water Treatment) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Antiviral Combination Therapy Global Market Report 2024 – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase Inhibitor/Nucleotide Reverse Transcriptase Inhibitors, Nucleotide Reverse Transcriptase Inhibitors, Nucleotide Reverse Transcriptase Inhibitors/Protease Inhibitor, Other Drug Combinations), By Route Of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By Indication (Human Immunodeficiency Virus, Hepatitis, Other Indications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Viral Gastroenteritis Global Market Report 2024 – By Drugs (Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs), By Diagnosis (Physical Examination, Rapid Stool Test), By Indication (Watery Diarrhea, Abdominal Cramps, Pain, Other Indications), By Type Of Virus (Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus), By End User (Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Viral Vector Manufacturing Global Market Report 2024 – By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Workflow (Upstream Processing, Downstream Processing), By Application (Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research), By End-User (Research Organizations, Biotech And Pharmaceutical Companies, Others End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the adeno-associated viral vectors market?

Adeno-associated viral vectors (AAV) are small, non-pathogenic viruses commonly used in gene therapy. They are engineered to deliver therapeutic genes into target cells, offering potential treatments for genetic disorders, cancers, and other diseases. AAV's safety profile and ability to efficiently infect both dividing and non-dividing cells make them valuable tools in biomedical research and clinical applications. For further insights on the adeno-associated viral vectors market, request a sample here

How will the adeno-associated viral vectors market drivers and restraints affect the adeno-associated viral vectors market dynamics? What forces will shape the adeno-associated viral vectors industry going forward?

The adeno-associated viral vectors market major growth driver - Rising Prevalence Of Genetic Disorders Fuels Growth In The Adeno-Associated Viral Vectors Market. For further insights on the adeno-associated viral vectors market, request a sample here

What is the forecast market size or the forecast market value of the adeno-associated viral vectors market?

The adeno-associated viral vectors market size has grown rapidly in recent years. It will grow from $2.29 billion in 2023 to $2.69 billion in 2024 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to vaccine development, increased funding and investment, academic and industrial collaborations, expansion of clinical trials, and public awareness and advocacy. The adeno-associated viral vectors market size is expected to see rapid growth in the next few years. It will grow to $5.17 billion in 2028 at a compound annual growth rate (CAGR) of 17.7%. The growth in the forecast period can be attributed to expanding therapeutic applications, increasing the prevalence of genetic disorders, and neurological disorders, regulatory approvals and support, and cost reductions in production. Major trends in the forecast period include gene therapy advancements, technological innovations, scalable manufacturing processes, collaborations and investments, and technological advancements. For further insights on the adeno-associated viral vectors market, request a sample here

How is the adeno-associated viral vectors market segmented?

The adeno-associated viral vectors market is segmented
1) By Type Of Therapy: Gene Augmentation, Immunotherapy, Other Type Of Therapies
2) By Type Of Gene Delivery Method Used: Ex Vivo, In Vivo
3) By Target Therapeutic Area: Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By Application Area: Gene Therapy, Cell Therapy, VaccinesFor further insights on the adeno-associated viral vectors market, request a sample here

Which region has the largest share of the adeno-associated viral vectors market? What are the other regions covered in the report?

North America was the largest region in the adeno-associated viral vectors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adeno-associated viral vectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the adeno-associated viral vectors market, request a sample here.

Who are the major players in the adeno-associated viral vectors market?

Major companies operating in the adeno-associated viral vectors market are Pfizer Inc., Astellas Pharma, Biogen Inc., Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics, Ultragenyx Pharmaceutical, Amicus Therapeutics Inc., Oxford Biomedica, Asklepios BioPharmaceutical Inc., uniQure biopharma B.V., Spark Therapeutics Inc., Akouos inc., Adverum Biotechnologies Inc., Passage Bio Inc., AVROBIO Inc, MeiraGTx Holdings plc, GenSight Biologics S.A., Freeline Therapeutics, Aspa Therapeutics Inc., Adrenas Therapeutics Inc., 4D Molecular Therapeutics, Abeona Therapeutics Inc., Neurophth Therapeutics For further insights on the adeno-associated viral vectors market, request a sample here.

What are the key trends in the adeno-associated viral vectors market?

Major trend in the adeno-associated viral vectors market - Advancements In Off-the-Shelf Rep/Cap Plasmids. For further insights on the adeno-associated viral vectors market, request a sample here.

What are the major opportunities in the adeno-associated viral vectors market? What are the strategies for the adeno-associated viral vectors market?

For detailed insights on the major opportunities and strategies in the adeno-associated viral vectors market, request a sample here.

How does the adeno-associated viral vectors market relate to the overall economy and other similar markets?

For detailed insights on adeno-associated viral vectors market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the adeno-associated viral vectors industry?

For detailed insights on the mergers and acquisitions in the adeno-associated viral vectors industry, request a sample here.

What are the key dynamics influencing the adeno-associated viral vectors market growth? SWOT analysis of the adeno-associated viral vectors market.

For detailed insights on the key dynamics influencing the adeno-associated viral vectors market growth and SWOT analysis of the adeno-associated viral vectors industry, request a sample here.